Global Respiratory Inhalers Market | The key players are Beximco

The market size of the global Respiratory Inhalers Market in 2021 is valued at 35.03 Billion and is projected to reach 61.29 Billion by 2030 at a CAGR of 6.7% during the forecast period.

Curious about this latest version of the report? Get report [email protected]

As respiratory dysfunction is one of the most common health problems in the world, the respiratory care market has a strong presence in the medical field. The increasing incidence of certain respiratory diseases, such as COPD and asthma, the substantial increase in the number of elderly patients (the majority of whom suffer from at least one type of respiratory condition) and the growing awareness of certain problems airway obstruction, such as sleep apnea and the general increase in demand for improved patient care are all drivers of growth. Respiratory inhalers have frequently saved the lives of millions of patients. Asthmatics, COPD, and pulmonary arterial hypertension are the most common patient groups who use inhalers. As their immunity to chronic and lung disease deteriorates, the growing geriatric population is also turning to inhalers.

Respiratory inhalers include complementary spacers or holding chamber devices to reduce deposition in the mouth and throat. Breathing inhalers are increasingly being used to treat patients with COPD (chronic obstructive pulmonary disease) and asthma. Combination therapy is more widely used because it has demonstrated its reliability and effectiveness in complex patients. The proposed shift to home healthcare is expected to further boost the respiratory products market.

List of Key Players of Global Respiratory Inhalers Market:
Boehringer Ingelheim
Astra Zeneca
Propeller Health
Beximco Pharmaceuticals (Beximco Pharma)
H&T Presspart
Cohero Health
CHIESI Pharmaceuticals
Lucky’s Pharma
Amiko Digital Health
Teva Pharmaceutical Industries
Vectura Group
Health Spray

For more information @

Market dynamics:
Drivers –
The increased prevalence of asthma is expected to drive the growth of the global respiratory inhalers market over the forecast period. According to The Global Asthma Report 2018, approximately 300 million people worldwide have asthma, and this number is expected to reach 100 million by 2025. Additionally, the high prevalence of chronic obstructive pulmonary disease (COPD) is expected to underpin the market growth. According to the Global Initiative for Chronic Obstruction Disease 2018 report, COPD is expected to cause 4.5 million deaths globally annually by 2030. The market is expected to witness significant growth over the forecast period owing to the rapid technological progress and the many initiatives taken. by the governments of different nations to combat respiratory diseases by raising awareness of the symptoms and making new treatments easily accessible.

Challenges –
Rising cost of inhalers is a major impediment to the growth of the global respiratory inhalers market. For example, the average cost of an Advair inhaler increased from $316 million in 2013 to $496 million in 2018, while that of Flovent increased from $207 million in 2013 to $292 million in 2018. increasing adoption of alternative therapies such as oral medications or subcutaneous injections which are freely available in various public hospitals especially in emerging economies and some other non-profit organizations are expected to limit the market growth over the course of the forecast period.

Regional trends:
The North America respiratory inhalers market is expected to register a majority market share in terms of revenue and market share and is expected to grow at a high CAGR during the forecast period. An increase in asthma cases and the presence of well-known players are the key factors that are expected to proliferate the growth of the respiratory inhalers market in this region. Another important factor supporting growth is the region’s high level of healthcare spending. For example, according to preliminary projections from the CMS Office of the Actuary, overall health care spending in the United States is expected to grow by 5.4% between 2019 and 2028, outpacing GDP growth by 4.3%. In addition, Asia-Pacific is expected to hold a substantial share of the market due to rising geriatric population, growing awareness of lung disease, and rising healthcare expenditure in the region.

• In February 2022, Honeywell announced a commercial collaboration with AstraZeneca (LON: AZN) to develop and commercialize next-generation respiratory inhalers that use propellants with near-zero global warming potential (GWP) to treat asthma and chronic obstructive pulmonary disease (COPD). The next-generation inhaler will use Honeywell’s Solstice® Air to reduce greenhouse gas emissions from the propellant by up to 99.9% compared to the existing inhaler propellant.
• In July 2020, Novartis collaborated with Propeller to package and ship its enerzair breezhaler with Propeller’s digital sensor tracking platform in Europe to treat patients with poorly controlled asthma. This has enhanced the company’s product portfolio while providing lucrative growth opportunities in the smart inhaler market.
• In May 2020, Aptar Pharma acquired the assets of Cohero Health, a leading digital company focused on developing cost-effective digital solutions to improve respiratory care. Aptar’s digital portfolio in the respiratory disease management industry has grown as a result, driving the segment’s revenue growth.

Global Respiratory Inhalers Market Segmentation –
By Products –
• Measured dosage
• Dry powder inhaler
• Nebulizers
• Compressed air nebulizers
• Ultrasonic nebulizers
• Mesh nebulizers

By patients –
• Adults
• Pediatric

By technology –
• Manual inhalers
• Digitally controlled inhalers

By end users –
• Hospital pharmacies
• Detail
• On line

By region –
North America –
• United States
• Canada
• Mexico

Europe –
• Germany
• Great Britain
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific –
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia-Pacific

Latin America –
• Brazil
• Argentina
• Rest of Latin America

Middle East and Africa –
• GCC countries
• South Africa
• Rest of the Middle East and Africa

Request for ToC/Proposal:

InsightAce Analytics Pvt. ltd.
Such. : +1 551 226 6109
Email: [email protected]
Site visit:
Follow us on LinkedIn @
Follow us on Facebook @

InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market intelligence and competition to grow businesses. We help our clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in delivering syndicated and customized market intelligence reports with in-depth analysis with key market insights in a timely and cost effective manner.

This press release was published on openPR.